本页面由Tiger Trade Technology Pte. Ltd.提供服务

福泰制药

509.50
-0.5800-0.11%
成交量:47.59万
成交额:2.43亿
市值:1,292.70亿
市盈率:29.65
高:514.80
开:512.44
低:506.00
收:510.08
52周最高:560.25
52周最低:402.58
股本:2.54亿
流通股本:2.54亿
量比:0.55
换手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):17.18
每股收益(LYR):15.32
净资产收益率:23.54%
总资产收益率:11.93%
市净率:6.38
市盈率(LYR):33.26

数据加载中...

2026/05/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/02

SEC问询函

Form CORRESP - Correspondence
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities